Company DescriptionTristel PLC is a player in the healthcare platform. The company is a manufacturer of infection prevention and contamination control products. Its core product candidate is a chlorine dioxide formulation. Its operating segments include Hospital medical device decontamination and Hospital environmental surface disinfection. It caters to three market avenues: The Human Healthcare market, The Contamination Control market, and the Animal Healthcare market. The Human Healthcare division deals with hospital infection prevention and accounts for most of the company's revenues.

How the Company Makes Money

Tristel Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Breakdown
Income Statement		Total Revenue
41.93M	36.01M	31.12M	31.00M	31.68M
	Gross Profit
30.87M	29.18M	24.66M	24.74M	25.25M
	EBIT
7.05M	5.28M	4.20M	4.76M	6.80M
	EBITDA
10.01M	7.84M	4.46M	6.70M	9.30M
	Net Income Common Stockholders
6.49M	4.46M	987.00K	3.66M	5.10M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
11.79M	9.54M	8.88M	8.09M	6.21M
	Total Assets
44.11M	41.37M	38.74M	39.93M	40.93M
	Total Debt
5.86M	5.18M	5.81M	5.91M	6.00M
	Net Debt
-275.00K	-1.93M	-3.07M	-2.19M	-210.00K
	Total Liabilities
11.70M	10.68M	9.75M	9.85M	12.47M
	Stockholders Equity
32.41M	30.68M	28.98M	30.08M	28.46M
Cash Flow		Free Cash Flow
10.06M	6.07M	4.35M	4.71M	4.61M
	Operating Cash Flow
11.20M	8.49M	5.55M	6.48M	6.99M
	Investing Cash Flow
-5.40M	-4.84M	-1.20M	-1.77M	-2.97M
	Financing Cash Flow
-6.57M	-5.44M	-3.62M	-2.83M	-2.02M

Tristel Peers Comparison

Overall Rating

UnderperformOutperform

Sector (49)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HLMA	80 Outperform	£10.49B	36.48	15.48%	0.80%	11.94%	20.48%
TSTL	74 Outperform	£169.34M	27.50	20.02%	3.81%	10.32%	1.25%
VCT	73 Outperform	£787.85M	45.80	3.73%	6.45%	-5.21%	-72.13%
JMAT	70 Outperform	£2.44B	5.01	4.54%	5.28%	-15.51%	200.70%
Sector *	49 Neutral	$7.05B	0.34	-55.09%	2.46%	25.27%	-3.43%

* Healthcare Sector Average

Performance Comparison

GB:TSTL

Tristel

355.00

-100.90

-22.13%

GB:CRDA

Croda International

3,264.00

-1,304.69

-28.56%

GB:HLMA

Halma plc

2,770.00

484.81

21.22%

GB:JMAT

Johnson Matthey

1,468.00

-104.58

-6.65%

GB:VCT

Victrex

946.00

-274.89

-22.52%

GB:SN

Smith & Nephew

1,177.00

129.18

12.33%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.